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Abstract
Background Current evidence suggests sodium bicarbon-
ate (NaHCO3) should be ingested based upon the individ-
ualised alkalotic peak of either blood pH or bicarbonate
(HCO3
-) because of large inter-individual variations
(10–180 min). If such a strategy is to be practical, the
blood analyte response needs to be reproducible.
Objective This study aimed to evaluate the degree of
reproducibility of both time to peak (TTP) and absolute
change in blood pH, HCO3
- and sodium (Na?) following
acute NaHCO3 ingestion.
Methods Male participants (n = 15) with backgrounds in
rugby, football or sprinting completed six randomised
treatments entailing ingestion of two doses of 0.2 gkg-1
body mass (BM) NaHCO3 (SBC2a and b), two doses of
0.3 gkg-1 BM NaHCO3 (SBC3a and b) or two control
treatments (CON1a and b) on separate days. Blood analysis
included pH, HCO3
2 and Na? prior to and at regular time
points following NaHCO3 ingestion over a 3-h period.
Results HCO3
- displayed greater reproducibility than pH
in intraclass correlation coefficient (ICC) analysis for both
TTP (HCO3
- SBC2 r = 0.77, P = 0.003; SBC3 r = 0.94,
P\ 0.001; pH SBC2 r = 0.62, P = 0.044; SBC3
r = 0.71, P = 0.016) and absolute change (HCO3
- SBC2
r = 0.89, P\ 0.001; SBC3 r = 0.76, P = 0.008; pH
SBC2 r = 0.84, P = 0.001; SBC3 r = 0.62, P = 0.041).
Conclusion Our results indicate that both TTP and abso-
lute change in HCO3
- is more reliable than pH. As such,
these data provide support for an individualised NaHCO3
ingestion strategy to consistently elicit peak alkalosis
before exercise. Future work should utilise an individu-
alised NaHCO3 ingestion strategy based on HCO3
-
responses and evaluate effects on exercise performance.
Key Points
Although both the blood pH and bicarbonate
(HCO3
-) response following ingestion of sodium
bicarbonate (NaHCO3) displays good test–retest
reliability, the HCO3
- response is more
reproducible. Therefore, an individualised NaHCO3
ingestion strategy should be based on time to peak
HCO3
-.
Large inter-individual variations in achieving both
peak pH and HCO3
- suggest an individualised
NaHCO3 ingestion strategy based on time to peak
HCO3
- would be most appropriate to increase
potential ergogenic effects on performance.
Within the first 60 min following ingestion of 0.2 or
0.3 gkg-1 body mass NaHCO3, the acid–base
balance kinetics are similar, meaning smaller doses
of NaHCO3 may be appropriate when\60 min is
available, particularly for individuals who
experience gastrointestinal discomfort.
1 Introduction
Nutritional ergogenic aids that delay metabolic acidosis
during high-intensity exercise have been widely investi-
gated [5, 16, 38]. In particular, exogenous enhancement of
the bicarbonate buffering systems is thought to have an
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important role in offsetting the metabolite fatigue process
by dampening critical rises in hydrogen cations (H?) [17].
Ingestion of a known alkalotic buffer, sodium bicarbonate
(NaHCO3), can achieve ergogenic effects by increasing
blood bicarbonate concentration [HCO3
2] within extra-
cellular fluid by 4–8 mmolL-1 [34], which typically
relates to peak alkalosis [32]. The most common ingestion
practices include doses of 0.2–0.3 gkg-1 body mass (BM)
NaHCO3; lower amounts are considered insufficient to
induce a level of peak alkalosis that would improve per-
formance [34]. Doses above this concentration exacerbate
the incidence and severity of gastrointestinal (GI) dis-
comfort [16].
Multiple studies using group mean data have reported
wide variations in time to peak (TTP) alkalosis (i.e. HCO3
-
or pH ) following various doses of NaHCO3 [7, 28, 31, 32].
Peak HCO3
- has been observed at 40 and 60 min fol-
lowing 0.2 and 0.3 gkg-1 BM NaHCO3, respectively [31],
whereas others have observed peaks at 90 [28], 120 [7] and
180 min [32]. Differences may be due to either sampling
rate (20–60 min) or inter-individual variations since it is
possible that individual blood pH and HCO3
- absorption
characteristics were overlooked [7, 28, 31, 32]. Conse-
quently, this generic approach has led to potential reduc-
tions or variations in ergogenic effects [8, 30]. More
specifically, Froio de Araujo Dias et al. [8] reported
inconsistent performance responses following ingestion of
NaHCO3 during 110% peak power output cycling time to
exhaustion (TTE). Recreationally active participants
(n = 15) consumed 0.3 gkg-1 BM NaHCO3 on four
occasions or a placebo on two occasions. Only one par-
ticipant experienced ergogenic effects with all NaHCO3
treatments, and five did not improve with any treatment.
This suggests some degree of intra-individual variation,
which may be a result of intra-individual blood responses,
although this is difficult to define because only group mean
blood responses were reported.
A contemporary approach is to individualise the inges-
tion strategy; Stannard et al. [34] reported large inter-in-
dividual variations in TTP HCO3
2 (0.2 gkg-1
BM = 40–165 min; 0.3 gkg-1 BM = 75–180 min).
These findings challenge the results of the aforementioned
studies, which reported group-level analysis following
NaHCO3 supplementation at a fixed timeframe
[17, 30, 31]. Furthermore, variations in TTP HCO3
-
arguably provide insight into the commonly reported inter-
and intra-individual variations in performance following
NaHCO3 ingestion [8, 30], as participants may not have
reached peak alkalosis before commencing exercise [17].
Recent work by Miller et al. [18] supports this claim. These
authors found that total work done (TWD) during repeated
sprint cycling (10 9 6 s) improved by 11% with an indi-
vidualised ingestion strategy [18], a response greater than
the 5% improvement in a similar study employing a stan-
dardised ingestion strategy [3].
Further research is necessary to identify individualised
NaHCO3 ergogenic strategies that elicit peak alkalosis.
Equally important for practical application in the field is a
better understanding of the reproducibility of blood ana-
lytes (pH and HCO3
-) following acute ingestion of
NaHCO3. Daily biological variations, either short term or
long term, may occur in response to changes in nutritional
practices and therefore effect daily acid load fluxes (po-
tential renal acid load [PRAL]) [22, 26, 27] with the
potential to affect the reproducibility of TTP alkalosis. This
may then negatively affect the efficacy and consistency of
an individualised NaHCO3 ingestion strategy intended to
improve exercise performance. Therefore, the aim of this
study was to assess the reproducibility of the individual
blood pH, HCO3
- and Na? response following acute
ingestion of 0.2 or 0.3 gkg-1 BM doses of NaHCO3.
2 Materials and Methods
2.1 Participants
Participants were recruited on the basis that they may gain
a performance benefit from enhancing their buffering
capacity [17]. In total, 16 participants in team or individual
sports with backgrounds in rugby, football or running
volunteered for this single-blind randomised crossover
study. One participant withdrew from the study because of
GI upset (vomiting) after the first dose of NaHCO3
0.3 gkg-1 BM; therefore, 15 males (n = 5 rugby, n = 7
football, n = 3 sprinting) completed the study (height
1.81 ± 0.06 m, BM 84 ± 8 kg, age 21 ± 2 years, maxi-
mal oxygen uptake [VO2max] 52.1 ± 2.2 ml.kg
-1.min-1).
Participants habitually completed four (±1) exercise bouts
per week lasting 2 (±0) h per session and had 10 (±3)
years’ training experience within their respective sports.
Ethical approval was obtained from the Departmental
Research Ethics Committee (SPA-REC-2015-325), and
each participant provided written informed consent and
completed a health screening procedure prior to data col-
lection. The research was conducted in accordance with the
Helsinki declaration. Participants were verbally screened to
ensure no NaHCO3 or similar intracellular or extracellular
buffers such as beta alanine had been ingested during the
6 months prior to, or outside of, the experimental
conditions.
2.2 Pre-Experimental Procedures
Participants visited the laboratory on seven occasions 4 h
after eating and at the same time of day to minimise the
L. A. Gough et al.
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effects of circadian rhythms [25]. Participants were
required to avoid alcohol and any strenuous/unaccustomed
exercise during the 24-h period before the experimental
treatment [29]. Caffeine and spicy foods were also pro-
hibited 12 h before experimental treatments to avoid any
influence on metabolic regulation [15, 39]. Compliance
with the above procedures was checked via a written log of
nutritional intake 24 h prior to each experimental treat-
ment, which was replicated for each visit (adher-
ence = 100%) and later analysed for reproducibility.
Treatments were conducted at least 7 days apart to allow
for washout of residual NaHCO3 [3]. The NaHCO3 used in
this study was purchased from the manufacturer and stored
safely according to laboratory guidelines to avoid con-
tamination by other stimulants.
2.3 Maximal Oxygen Uptake Protocol
An incremental ramp VO2max test on an electromagneti-
cally braked cycle ergometer (Lode Excalibur, Germany)
was initially conducted. After a 5-min warm-up (70 W),
participants began cycling at their respective self-selected
cadence at a power output of 75 W (ten participants at 80
r.min-1; five participants at 90 r.min-1). This then
increased by 1 W every 2 s (30 W.min-1) until volitional
exhaustion. Samples were continuously analysed using a
gas analyser (Cosmed, K5, Italy) for oxygen consumption
(VO2), carbon dioxide expired (VCO2) and respiratory
exchange ratio (RER). Data were averaged over the last
30 s of exercise to determine the VO2max.
2.4 Main Treatment Arms
The subsequent six treatments were administered in a block
randomised manner and involved two treatment arms of no
treatment (CON1a, CON1b) to assess daily variations in
blood analytes, two treatment arms requiring ingestion of
NaHCO3 0.2 gkg-1 (SBC2a, SBC2b), and two treatment
arms requiring ingestion of NaHCO3 0.3 gkg-1 BM
(SBC3a, SBC3b). Solutions were prepared by a laboratory
technician not involved with the research: 400 ml of water
was mixed with 50 ml of flavoured sugar-free drink con-
centrate and refrigerated to enhance palatability [18].
Treatments were administered single blind, and partici-
pants consumed the drink within the first 10 mins of the
180 min experimental procedures [34].
An arterialised finger prick capillary blood sample was
obtained from participants in a rested and seated state prior
to NaHCO3 ingestion. Arterialisation was achieved by
warming the hand with a heated blanket (45 C) for 5 min
prior to taking each individual sample [13]. After ingestion
of NaHCO3, a further 15 blood samples were obtained over
a 180-min period in each treatment (Table 1). At multiple
time points, a GI questionnaire (visual analogue scale
[VAS] where 0 = no instance and 10 = most severe) that
included a range of symptoms was completed as per pre-
vious research [18] (Table 2). Participants remained seated
throughout, with only toilet breaks permitted. No food was
allowed to be consumed during this period, and water was
consumed ab libitum, with total volume replicated in
subsequent treatment arms. Blood samples were collected
in 100-ll heparin-coated clinitubes (Radiometer Medical
Ltd, Denmark) and subsequently analysed for blood pH,
HCO3
- and Na? (ABL800 BASIC, Radiometer Medical
Ltd). This radiometer has demonstrated a low bias in pH,
PCO2 and Na
? [24] and a correlation coefficient of
r[ 0.98 for both HCO3
- and pH against other commer-
cially available blood gas analysers [35]. Moreover, a small
pilot study (n = 8) in our laboratory also revealed high
test–retest reliability for both HCO3
- (16 samples: coeffi-
cient of variation [CV] 3.0–4.9%) and pH (16 samples: CV
0.17–0.20%) at both resting levels and following NaHCO3
ingestion.
2.5 Statistical Analysis
We conducted an a priori power calculation using the
statistical software package SPSS Sample Power 3 (IBM,
Chicago, IL, USA). Based upon the expected population
correlation of r = 0.80 between both NaHCO3 conditions
(SBC2 and SBC3), a minimum of 11 participants was
required to achieve 80% power (P\ 0.05).
Assessed variables were initially analysed for normality
(Shapiro–Wilks and Q–Q plots) and homogeneity of vari-
ance/sphericity (Mauchly). To assess the differences
between conditions, t tests were used. For non-normally
distributed data, a Mann–Whitney U test was used with Z
score and significance reported (e.g. GI data). Likewise, the
appropriate correction was applied (Greenhouse Geisser)
for violations of sphericity. Both one-way (treatment) and
two-way (treatment 9 time) repeated measured analysis of
variation (ANOVA) was used to analyse differences in
blood parameters with Bonferroni corrections applied.
Tukey’s honestly significant difference (HSD) post hoc
analysis was carried out to assess interactions by calcu-
lating the minimal difference required between means to
confirm significance had been achieved [37]. Statistical
significance was set at P[ 0.05.
Limits of agreement (LOA) with 95% limits and Bland–
Altman plots were utilised for within-subject variance and to
determine whether data were heteroscedastic [4]. This
method is widely used [19, 33] and accounts for bias between
the mean differences [9]. Intraclass correlation coefficients
(ICCs) were displayed with r value and significance level, as
per previous recommendations [1]. CV is reported using
standard deviation (SD)/mean 9 100. Correlation between
The Reproducibility of Blood Acid Base Responses Following NaHCO3
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TTP HCO3
- and pH was calculated using Pearson’s corre-
lation, from Hopkins’ spreadsheet [12]. Statistical proce-
dures were completed using SPSS version 22, and
calculations were carried out using Microsoft Excel 2013
(Microsoft Inc., Redmond, WA, USA).
3 Results
3.1 Nutritional Intake
Total daily calorie (r = 0.78, P\ 0.001; mean ± SD
2283 ± 75), carbohydrate (r = 0.97, P\ 0.001;
253 ± 4 g), protein (r = 0.98, P\ 0.001; 85 ± 2 g) and
fat (r = 0.97, P\ 0.001; 126 ± 3 g) intake were all
highly reproducible for all treatments.
3.2 Gastrointestinal Upset
Both the severity and the TTP GI upset displayed excellent
reproducibility in SBC2 and SBC3 (severity: SBC2
r = 0.92, P\ 0.001; LOA: B –0.5, -3.1, ?2.2; TTP:
SBC2 r = 0.91, P\ 0.001; LOA: B 5, -38, ?47 vs.
severity SBC3 r = 0.90, P\ 0.001; LOA: B -0.4, -4.7,
?3.8; TTP SBC3 r = 0.78, P = 0.005; LOA: B 7, -64,
77). In total, 10 of the 15 participants reported symptoms of
GI upset in both SBC2 and SBC3; the specific symptoms
are depicted in Table 2. The severity of upset was lower in
SBC2 than in SBC3 (mean 2.0 vs. 3.6), but the difference
was not significant (Z = 0.922, P = 0.356). In SBC2 TTP
GI upset was established ealier compared to SBC3 (mean
29 vs. 36 min), but this was also not significant
(Z = 0.439, P = 0.661).
3.3 Reproducibility of Blood pH, Bicarbonate
and Sodium
Baseline measures for both HCO3
- (r = 0.83, P\ 0.001)
and Na? (Na? r = 0.86, P\ 0.001) displayed excellent
reproducibility and pH displayed good reproducibility
(r = 0.66, P = 0.002). Values for ICCs across the 3-h sam-
pling period ranged from fair to excellent (r = 0.530–0.914)
for pH in SBC2 and from good to excellent (r = 0.76–0.92) in
SBC3 upon excluding two poor values at 80 (r = 0.05) and
85 min (r = 0.01). Reproducibility for HCO3
- in SBC2
demonstrated excellent reproducibility (r = 0.76–0.87) and
SBC3 displayed good to excellent (r = 0.65–0.87) repro-
ducibility across all time points (Table 1).
Greater reproducibility of TTP HCO3
- was demon-
strated for SBC3 (ICC: r = 0.94, P\ 0.001; LOA: B 2.3,
-15.9, ?20.5) compared to SBC2 (ICC: r = 0.77,
P = 0.003; LOA: B -6, -36, ?24). Likewise, TTP pH
demonstrated a greater reproducibility for SBC3 (ICC:
r = 0.71, P = 0.016; LOA: B 2.3, -37.3, ?42) than for
SBC2 (ICC: r = 0.62, P = 0.044; LOA: B 2.3, -39.3,
?42). The correlation between TTP pH and TTP HCO3
-
was greater in SBC2 (r = 0.61 and r = 0.66, respectively)
than in SBC3 (r = 0.26 and r = 0.17, respectively). The
relationship between TTP Na? was greater for SBC2 (ICC:
r = 0.75, P = 0.838; LOA: B 8.7, ?41.8, -73.2) than for
SBC3 (ICC: r = 0.56, P = 0.061; LOA: B 15, ?44.4,
-71.9), but neither were significant in ICCs and displayed
considerable bias in LOA analysis.
Absolute change (peak change from baseline) for HCO3
-
displayed high reproducibility for SBC2 (ICC: r = 0.90,
P\ 0.001; LOA: B 0.1, -0.9, ?1.1) compared with SBC3
(ICC: r = 0.76, P = 0.008; LOA: B 0.1, -1.9, ?2.0). The
absolute change in pH was highly reproducible in SBC2
(ICC: r = 0.84, P = 0.001; LOA: B -0.1, -0.04, ?0.03)
compared with SBC3 (ICC: r = 0.62, P = 0.041; LOA: B
0.01,-0.04,?0.05). In contrast, the absolute change in Na?
displayed no relationship in either SBC2 (ICC: r = 0.10,
P = 0.562; LOA: B 0.1, -4.9, ?5.1) or SBC3 (ICC:
r = 0.10, P = 0.425; LOA: B 1.3, -6.2, ?8.7).
3.4 Differences Between Treatments
There was no significant difference in TTP HCO3
- between
SBC2 and SBC3 (allP[0.05) (Table 3). Conversely, TTP pH
occurred significantly later in SBC3a than in SBC2a (?17 min;
P\0.026) but non-significantly later in SBC3b than in SBC2b
(?8 min; P = 0.392) (Table 3). In SBC3a, TTP Na? occured
significantly later than in SBC2a (?32 min; P = 0.027) and
25 min later in SBC3b than in SBC2b (P = 0.061). A large
inter-individual variation in TTP pH, HCO3
- and Na? was
observed in both SBC treatments (Table 3).
The absolute change in blood analytes HCO3
- and pH
can be observed in Table 3. Absolute change in HCO3
-
was greater in SBC3 than in SBC2 (P\ 0.001). Absolute
pH change was significantly greater in SBC3a than in
SBC2a (?0.2; P = 0.018) but not in SBC2b and SBC3b
(?0.1; P = 0.242). Absolute change in Na? was signifi-
cantly greater in SBC3 than in SBC2 (P[ 0.05; Fig. 1). A
large inter-individual variation in absolute change of pH,
HCO3
- and Na? was observed in both SBC2 and SBC3
(Table 3). Lastly, up to 60 min post NaHCO3 ingestion,
neither HCO3
- nor pH were significantly different between
SBC2 and SBC3 (both P[ 0.05; Fig. 1).
4 Discussion
This is the first study to investigate the reproducibility of
individual blood analytes pH, HCO3
- and Na? following
acute induced metabolic alkalosis. Our findings suggest
blood pH and HCO3
- are highly reproducible in most
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participants (13 of 15), whereas Na? displays poor repro-
ducibility. Given that TTP and absolute change reflected
greater reproducibility for HCO3
- and correlation was
lacking between pH and HCO3
- (no to moderate correla-
tion; Sect. 3.2), prior knowledge of HCO3
- absorption
characteristics following NaHCO3 ingestion is essential. As
such, practitioners and athletes should develop their
respective NaHCO3 dosing strategies based on TTP
HCO3
-.
These results challenge the common ingestion strategy
of NaHCO3 0.3 gkg-1 BM 1–4 h before exercise
[16, 28, 32] because a large inter-individual variation in
TTP alkalosis is evident (Table 3). For instance, the
absolute changes in HCO3
- observed in this study for
SBC2 (*5.7 mmolL-1) and SBC3 (*7.1 mmolL-1)
(Table 3) were greater than the typical change with stan-
dardised ingestion strategies [31]. This is also within the
range of absolute change that is suggested to be required to
potentially produce ergogenic effects ([5 mmolL-1 [6]).
Moreover, in light of similar reports of inter-individual
variations [18, 32, 34], a standardised ingestion strategy is
not suitable to heighten the potential ergogenic effects from
alkalotic substances (i.e. NaHCO3 and sodium citrate).
Rather, an individualised ingestion strategy is more rele-
vant to optimise peak alkalosis and, therefore, individuals
should identify their respective alkalotic peak.
TTP HCO3
- was achieved considerably earlier in the
present study (\90 min) than in previous work ([95 min)
that adopted the same ingestion window (10 min) [34].
Both studies controlled nutritional intake and employed the
same 4-h post-prandial strategy; however, as 10% of food
is suggested to be present in the stomach even after a 4-h
fast [34], small contributions from meal volume, compo-
sition and texture may have produced equivocal time-
frames. However, it is more plausible that the differences
in NaHCO3 administration (solution vs. capsule) between
studies explains the discrepancies in TTP given the dif-
ferential rapid emptying of liquids versus the slower
emptying of solids [11]. In support, TTP HCO3
- has
occurred earlier in other studies that administered NaHCO3
via solution [6, 18, 23, 28, 30] compared with capsules
[6, 30, 34]. In future, individuals should consider the time
until competition/exercise and the palatability of NaHCO3
as a solution versus the large number of capsules (*20)
required within their respective ingestion strategies.
In some participants, the absolute HCO3
- change lacked
reproducibility (SBC3 n = 6; SBC2 n = 2), with differ-
ences[1 mmolL-1 observed (Table 3). For instance,
participant 1 elicited a 6.9 mmolL-1 change in HCO3- in
SCB3a compared with a 5.6 mmolL-1 change in SBC3b.
Furthermore, two participants did not reproduce a similar
TTP HCO3
-, with over 15 min difference between SBC2
and SBC3 (Table 3). It is unclear why this occurred given
that participants replicated nutritional intake. Nonetheless,
some individuals may require a test–retest to evaluate the
reproducibility of the absolute change in HCO3
-, which
presents a logistical limitation to the practitioner/athlete.
Whether such discrepancies would translate to a lack of
consistency in the performance response is unknown;
however, McNaughton [16] demonstrated that differences
Table 2 The most severe individual symptom of gastrointestinal upset experienced following ingestion of sodium bicarbonate 0.2 or 0.3 gkg-1
body mass
Participant SBC2a SBC2b SBC3a SBC3b
1 None None None None
2 Flatulence None None None
3 Flatulence None Bowel urgency Bowel urgency
4 Stomach cramp Belching Belching Stomach ache
5 None None None None
6 None None None None
7 Stomach bloating Stomach cramp Bowel urgency Stomach ache
8 Stomach ache Nausea Stomach cramp Diarrhoea
9 Bowel urgency Bowel urgency None Stomach bloating
10 Stomach bloating Stomach bloating Stomach ache Stomach ache
11 Diarrhoea Diarrhoea Diarrhoea Diarrhoea
12 None None Bowel urgency None
13 Nausea Nausea Nausea Nausea
14 None None None None
15 None None None None
SBC2 0.2 gkg-1 body mass, SBC3 0.3 gkg-1 body mass
L. A. Gough et al.
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Fig. 1 Mean blood analyte
responses for blood bicarbonate,
pH and sodium following
control treatments (solid
squares), ingestion of sodium
bicarbonate 0.2 gkg-1 body
mass (SBC2; solid triangles)
and 0.3 gkg-1 body mass
(SBC3; solid circles). Some
error bars and timepoints (5-min
interval samples) are omitted for
clarity
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of around 1 mmolL-1 in HCO3- elicited different per-
formance responses. Future work should assess whether
discrepancies in either TTP or absolute change within such
individuals affects performance responses.
For four of the participants, the absolute change in
HCO3
- following SBC2 was not enhanced further fol-
lowing SBC3. For instance, participant 1 displayed a
minimal improvement of 0.1 mmolL-1 between SBC2
and SBC3. In comparison, participant 13 increased nearly
twofold between SBC2 (?4.8 mmolL-1) and SBC3
(?8.8 mmolL-1). This suggests identification of the
absolute HCO3
- change between different doses of
NaHCO3 is required, as some do not display any further
increase in HCO3
- from NaHCO3 doses[0.2 gkg-1 BM.
This indicates that ingestion of NaHCO3[0.2 gkg-1 BM
may not be warranted in individuals who display small
changes between NaHCO3 doses. This finding is of prac-
tical significance to individuals who experience GI upset
from a dose of 0.3 gkg-1 BM, given that the same acid–
base response can be elicited from a smaller dose. Further
research could evaluate whether both doses improve per-
formance to a similar extent in individuals who respond
this way.
This study found that HCO3
- and pH did not signifi-
cantly differ between SBC2 and SBC3 up to 60 min, which
supports previous findings [34]. This suggests it may be
possible for individuals to ingest a smaller dose if limited
time (\60 min) is available before exercise. This may be of
significance to individuals who participate in two bouts of
exercise with a small recovery time (e.g. track and field
athletes) or who experience GI upset, as lower doses have
been shown to reduce the severity and incidence of such
occurrences [16].
Inconsistencies in pH reproducibility observed in this
study could be explained by the breadth of factors that
affect pH, including contributions from intracellular
buffering such as carnosine, phosphocreatine and phos-
phates [10, 14]. Moreover, as ingestion of a NaHCO3 bolus
will initially and directly increase HCO3
- concentration,
the effect on pH is secondary and therefore may lead to
increased variability [10]. Variable pH has also been
observed in a recent study, even when HCO3
- was similar
[8]. For instance, following NaHCO3 ingestion, pH
increased by 0.045 ± 0.029 in one treatment but only by
0.027 ± 0.054 in another. Conversely, in the same treat-
ments, HCO3
- increased by 6.1 ± 2.3 and
5.9 ± 2.7 mmolL-1, but one of the limitations in this
study was that data were analysed at the group level and
only at two time points. Alternatively, the effect of nutri-
tional intake may have caused pH to vary. It is well known
that the acid/alkaline levels (PRAL) within nutritional
intake may affect the acid base balance [26, 27]. Therefore,
a limitation of this study is that participants completed a
nutrition log for only 24 h. Further research could inves-
tigate the effects of PRAL and longitudinal nutritional
practices on NaHCO3 absorption characteristics.
The Na? response displayed high intra-individual vari-
ability following NaHCO3 (Sect. 3.2; Fig. 1). In this study,
participants replicated nutritional practices prior to exper-
iments, and analysis revealed this was highly reproducible
(Sect. 3.1) but not specifically for Na? ingestion. There-
fore, small changes in total Na? ingested may explain these
findings. Moreover, whilst the volume of water was con-
trolled during experimental treatments, a limitation of this
study is that the frequency of ingestion was not measured,
which may also have affected Na? concentrations [20].
Nonetheless, whether small differences in total Na?
ingested or frequency of water consumption would account
for a meaningful change is unclear. An alternative but
speculative factor may be gastric emptying, as other work
[2, 21, 36] has suggested intra-individual variability. Our
analysis focused on blood Na?, so different quantities may
or may not have reached the bloodstream by the second
intake of the same NaHCO3 dose and consequently may
have produced equivocal responses.
We propose that disturbances to the acid base balance of
the stomach from high Na? load accompanying NaHCO3
ingestion can cause the onset of GI upset [34]. When
considering participants who experienced GI upset in this
study, TTP GI upset broadly corresponded with peak Na?
in SBC2 (peak GI upset *30 min, peak Na? 41 min) but
not as strongly in SBC3 (peak GI upset *35 min, peak
Na? *70 min). The absolute change in Na? was signifi-
cantly higher in SBC3 than in SBC2 (*2
vs. *6 mmolL-1); however, the incidence and severity of
GI upset did not differ significantly. Therefore, whether the
magnitude of change in Na? is useful in predicting the
onset of GI upset is unclear. Interestingly, the same
severity of nausea in SBC2 and diarrhoea in SBC3 was
observed in participant 8 (Table 2), with this theme
apparent for seven participants in total. As such, these
differences between doses will plausibly vary in the effects
on the ability to perform exercise. It is therefore important
to evaluate the severity of the specific symptom experi-
enced in the GI upset and make judgements on the
cost:benefit of NaHCO3 ingestion.
5 Conclusion
The blood analyte response following acute NaHCO3
ingestion is highly reproducible. The practitioner and/or
athlete should identify both the TTP and the absolute
change in HCO3
- to determine both the time and the
amount to ingest prior to using it in training or competition.
However, caution should be taken with participants who
The Reproducibility of Blood Acid Base Responses Following NaHCO3
123
displayed intra-individual variations in both TTP and
absolute change in HCO3
-, as NaHCO3 ingestion is
potentially unsuitable in these individuals. Future work
should investigate why some participants do not reproduce
a blood analyte response from NaHCO3 ingestion, includ-
ing investigation into the role of PRAL and longitudinal
nutritional practices. Lastly, given that both SBC2 and
SBC3 elicited a change in HCO3
- that may improve per-
formance, establishing the performance response utilising
an individualised NaHCO3 strategy is required.
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